Cluster headache pathophysiology—insights from current and emerging treatments

DY Wei, PJ Goadsby - Nature Reviews Neurology, 2021 - nature.com
Cluster headache is a debilitating primary headache disorder that affects approximately
0.1% of the population worldwide. Cluster headache attacks involve severe unilateral pain …

[HTML][HTML] Glutamate and its receptors as therapeutic targets for migraine

J Hoffmann, A Charles - Neurotherapeutics, 2018 - Elsevier
There is substantial evidence indicating a role for glutamate in migraine. Levels of glutamate
are higher in the brain and possibly also in the peripheral circulation in migraine patients …

Genetic studies of body mass index yield new insights for obesity biology

AE Locke, B Kahali, SI Berndt, AE Justice, TH Pers… - Nature, 2015 - nature.com
Obesity is heritable and predisposes to many diseases. To understand the genetic basis of
obesity better, here we conduct a genome-wide association study and Metabochip meta …

Novel anticonvulsant drugs

H Stefan, TJ Feuerstein - Pharmacology & therapeutics, 2007 - Elsevier
Principles of complex mechanisms of action of anticonvulsants including latest reports
concerning new antiepileptic drugs (AED) are considered. Different aspects of new …

Topiramate in migraine prevention: a 2016 perspective

SD Silberstein - Headache: The Journal of Head and Face …, 2017 - Wiley Online Library
Background In evidence‐based guidelines published in 2000, topiramate was a third‐tier
migraine preventive with no scientific evidence of efficacy; recommendation for its use …

Evidence-based pharmacotherapies for alcohol use disorder: clinical pearls

J Fairbanks, A Umbreit, BP Kolla, VM Karpyak… - Mayo Clinic …, 2020 - Elsevier
Pathologic alcohol use affects more than 2 billion people and accounts for nearly 6% of all
deaths worldwide. There are three medications approved for the treatment of alcohol use …

Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studies

A Gasparyan, D Navarro, F Navarrete… - Neuropharmacology, 2022 - Elsevier
Post-traumatic stress disorder (PTSD) is a disabling psychiatric condition with a critical
familiar, personal, and social impact. Patients diagnosed with PTSD show various …

The psychopharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants, and lithium

S Comai, M Tau, Z Pavlovic… - Journal of clinical …, 2012 - journals.lww.com
Patients experiencing mental disorders are at an elevated risk for developing aggressive
behavior. In the past 10 years, the psychopharmacological treatment of aggression has …

Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate

RP Shank, BE Maryanoff - CNS neuroscience & therapeutics, 2008 - Wiley Online Library
Topiramate (TPM; TOPAMAX®) is a broad‐spectrum antiepileptic drug (AED) that is
approved in many world markets for preventing or reducing the frequency of epileptic …

Targeting ionotropic glutamate receptors in the treatment of epilepsy

R Celli, F Fornai - Current Neuropharmacology, 2021 - ingentaconnect.com
Background: A dysfunction in glutamate neurotransmission is critical for seizure. Glutamate
is the major excitatory drive in the cerebral cortex, where seizures occur. Glutamate acts via …